Karen Mezzi
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.
Journal: American journal of respiratory and critical care medicine
Published: January 04, 2024
Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany.
Journal: Pulmonary therapy
Published: December 22, 2022
Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
Journal: Respiratory medicine
Published: December 15, 2022
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
Journal: Respiratory medicine
Published: December 12, 2022
Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 03, 2022
Impact of the UK lockdown on people at risk of COPD.
Journal: ERJ open research
Published: June 11, 2021
The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 17, 2020
Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials.
Journal: ERJ open research
Published: November 02, 2020
The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey.
Journal: International journal of chronic obstructive pulmonary disease
Published: August 06, 2020
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients.
Journal: NPJ primary care respiratory medicine
Published: July 02, 2020
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study.
Journal: The European respiratory journal
Published: March 01, 2020
Last Updated: 09/26/2026